Smaranda Bacanu

Artiklar

Article: CELL REPORTS. 2024;43(10):114784
Proteome-wide CETSA reveals diverse apoptosisinducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery
Ramos AD; Liang YY; Surova O; Bacanu S; Gerault M-A; Mandal T; Ceder S; Langeback A; Osterroos A; Ward GA; Bergh J; Wiman KG; Lehmann S; Prabhu N; Loof S; Nordlund P
Article: CELL CHEMICAL BIOLOGY. 2022;29(4):572-585.e8
CETSA interaction proteomics define specific RNA-modification pathways as key components of fluorouracil-based cancer drug cytotoxicity
Liang YY; Bacanu S; Sreekumar L; Ramos AD; Dai L; Michaelis M; Cinatl J; Seki T; Cao Y; Coffill CR; Lane DP; Prabhu N; Nordlund P
Article: SCIENTIFIC REPORTS. 2019;9(1):19384
CETSA-based target engagement of taxanes as biomarkers for efficacy and resistance
Langeback A; Bacanu S; Laursen H; Mout L; Seki T; Erkens-Schulze S; Ramos AD; Berggren A; Cao Y; Hartman J; van Weerden W; Bergh J; Nordlund P; Loof S
Article: PLOS ONE. 2017;12(3):e0173888
Nuclear localization of amyloid-β precursor protein-binding protein Fe65 is dependent on regulated intramembrane proteolysis.
Koistinen NA; Edlund AK; Menon PK; Ivanova EV; Bacanu S; Iverfeldt K
Article: NEUROSCIENCE LETTERS. 2016;613:54-59
Phosphorylation of Fe65 amyloid precursor protein-binding protein in response to neuronal differentiation.
Koistinen NA; Bacanu S; Iverfeldt K

Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2024